Category: Diagnostic Technologies

Diagnostic Technologies

Pictor Unveils High-Resolution Protein Analysis Platform at ADLM 2026

The research-use-only platform combines imaging, software, and multiplex protein analysis into a standard 96-well workflow designed to simplify biomarker research.

Diagnostic Technologies

Cancer Cell Diagnostics Launches New Blood Test for Cancer Profiling

The test uses intact circulating tumor cells instead of cell-free DNA fragments to analyze more than 500 genes and identify tumor markers.

Diagnostic Technologies

Experts Call for End to Routine ‘Corrected’ Calcium Reporting

A new position statement warns that albumin-adjusted calcium formulas are unreliable and may lead to patient misclassification.

Anatomic Pathology

AI Pathology Tool Predicts Immunotherapy Success in Rare Cancers

Researchers at MD Anderson have developed an AI-based pathology tool that predicts immunotherapy response in rare cancers by analyzing immune cell changes in biopsies, according to a Journal for ImmunoTherapy of Cancer study.

Digital Pathology

Global Study to Evaluate Syndromic PCR Testing for Infectious Diseases

Seegene has launched the Global Million Clinical Study to collect real-world data on the clinical utility of syndromic PCR testing for infectious diseases, aiming to inform future global diagnostic standards.

Clinical Chemistry

FDA Clears New Heart Disease Risk Test for Clinical Labs

The assay measures lipoprotein(a) levels in molar units to improve cardiovascular risk assessment and standardization across laboratories.

Flow Cytometry

Single-Cell Sequencing May Identify New Exercise Biomarkers

Research suggests new sequencing technologies can help labs move from tissue-level averages to cell-specific testing for precision exercise medicine.

Hematology & Serology

Stanford Blood Center Launches Infectious Disease Testing for Organ and Tissue Donors

The new service supports transplantation medicine for 13 million people across Northern California and Northern Nevada.

Immunoassay

Blood Test Detects Aggressive Prostate Cancer More Accurately Than PSA in Large Study

A3P Biomedical’s Stockholm3 test showed 90% sensitivity in detecting aggressive prostate cancer in a study of 12,670 men, outperforming traditional PSA screening.

Mass Spectrometry

University of Florida Researchers Develop Rapid Urine Test for Prostate Cancer

The noninvasive method uses paper spray and mass spectrometry to identify disease biomarkers in less than 30 seconds.

Microbiology

Study to Evaluate One-Hour Testing for Drug-Resistant Infections

The Fleming Initiative and Cepheid have launched a 30-month study in England to compare rapid molecular and traditional culture screening for drug-resistant carbapenemase-producing Enterobacterales in hospital settings.

Molecular Diagnostics

CareDx Completes Acquisition of Cancer Diagnostic Company

The deal adds a blood-based test for viral-mediated cancers to the company’s portfolio of transplant and cell therapy services.

Point-of-Care

Roche Receives FDA Clearance for Point-of-Care Bordetella Test

The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.

Urinalysis & Toxicology

Urine Metabolite Test Shows Potential for Autism Risk Screening

The screening tool identifies specific molecules produced by gut bacteria to distinguish children with autism from typically developing peers.